Covidien, Medtronic Settle Investor Suit Over $42.9B Merger
Covidien PLC and Medtronic Inc. on Tuesday agreed to a non-monetary settlement in a consolidated stockholder suit alleging that their proposed $42.9 billion merger undervalues Covidien and accusing Covidien directors of...To view the full article, register now.
Already a subscriber? Click here to view full article